<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262331/" ref="ordinalpos=1483&amp;ncbi_uid=3775456&amp;link_uid=PMC3262331" image-link="/pmc/articles/PMC3262331/figure/f3-jbm-1-093/" class="imagepopup">Figure 3.  From: L-CBM <span class="highlight" style="background-color:">signaling</span> in lymphocyte development and function. </a></div><br /><div class="p4l_captionBody">Schematic signaling pathway mediated by the L-CBM complex in NK cells.<b>Notes:</b> The L-CBM complex acts in the canonical NF-κB activation pathway through activating NK cell receptors (NKR) such as Ly49H, Ly49D, NK1.1, NKG2D, FcγRIII, etc. L-CBM might regulate MAPK activation through activating NKR, although this notion remains controversial. Similar to T cells, PKCθ activity is required for NF-κB activation through activating NKR. IL-18R-MyD88-mediated NF-κB activation does not require L-CBM in NK cells. While the PKCθ-L-CBM signaling is essential to cytokine/chemokine production, it is not necessary for cytotoxicity.</div></div>